Factor Xa Inhibitory Profile of Apixaban, Betrixaban, Edoxaban, and Rivaroxaban Does Not Fully Reflect Their Biologic Spectrum

The currently available oral anti-Xa agents are claimed to produce their anticoagulant and antithrombotic effects solely by the inhibition of factor Xa. This study profiled various anti-Xa drugs in routinely used laboratory assays to demonstrate that their effects are not solely related to the anti-...

Descripción completa

Detalles Bibliográficos
Autores principales: Siddiqui, Fakiha, Hoppensteadt, Debra, Jeske, Walter, Iqbal, Omer, Tafur, Alfonso, Fareed, Jawed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714936/
https://www.ncbi.nlm.nih.gov/pubmed/31088146
http://dx.doi.org/10.1177/1076029619847524

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714936/
https://www.ncbi.nlm.nih.gov/pubmed/31088146
http://dx.doi.org/10.1177/1076029619847524

Ejemplares similares